McGuire Capital Advisors’s YieldMax MRNA Option Income Strategy ETF MRNY Stock Holding History

McGuire Capital Advisors’s Portfolio MRNY Stock Details MRNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.38K	Sell	227 -1,291	-85%	-$21.8K	﹤0.01%	590
2026 Q1	$28.2K	Buy	1,518 +1,513	+30,260%	+$28.6K	0.02%	244
2025 Q4	$74	Buy	+5	New	+$80	﹤0.01%	926

Other funds holding MRNY

Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

WCM

Winebrenner Capital Management Louisville, Kentucky $164M AUM 12.81% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

KCM

Key Capital Management Hendersonville, Tn 37075, Tennessee $194M AUM

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

AAS

Ameritas Advisory Services Lincoln, Nebraska $4.96B AUM 27.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

McGuire Capital Advisors's MRNY Position: Q2 2026 in Review

McGuire Capital Advisors reduced its YieldMax MRNA Option Income Strategy ETF (MRNY) stake by 85% in Q2 2026, selling an estimated $21.8K and leaving 227 shares worth $4.38K. The position accounts for ﹤0.01% of the portfolio, ranked #590.

McGuire Capital Advisors first reported a position in MRNY in Q4 2025 and has held it in 3 quarters since. The position peaked at $28.2K in Q1 2026. 10 funds tracked by Wall St. Rank hold MRNY as of Q2 2026.

McGuire Capital Advisors held 227 shares of YieldMax MRNA Option Income Strategy ETF worth $4.38K as of Q2 2026.
McGuire Capital Advisors sold 1,291 YieldMax MRNA Option Income Strategy ETF shares in Q2 2026, an estimated $21.8K.
YieldMax MRNA Option Income Strategy ETF made up ﹤0.01% of McGuire Capital Advisors's portfolio in Q2 2026, its #590 holding.
McGuire Capital Advisors first reported a position in YieldMax MRNA Option Income Strategy ETF in Q4 2025 and has held it in 3 quarters since.
McGuire Capital Advisors's YieldMax MRNA Option Income Strategy ETF position peaked at $28.2K in Q1 2026.
10 funds tracked by Wall St. Rank held YieldMax MRNA Option Income Strategy ETF as of Q2 2026.

Based on McGuire Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.